These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 432552)

  • 21. De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphoma.
    Seignez A; Casasnovas O; Ferrant E; Bastie JN; Mondoloni P; Aho LS; Boulin M
    Int J Clin Pharm; 2015 Dec; 37(6):1033-7. PubMed ID: 26408407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative study of alpha-naphthyl acetate esterase-positive cells in Hodgkin's disease.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1982 Dec; 35(12):1301-6. PubMed ID: 6757271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disordered macrophage development in Hodgkin's disease shown by quantitative cytochemistry.
    Sokol RJ; Hudson G; Wales JM; Goldstein DJ; James NT
    Anal Quant Cytol Histol; 1993 Aug; 15(4):253-8. PubMed ID: 8397646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ; Andrieu JM
    MMW Munch Med Wochenschr; 1980 Jun; 122(25):932-4. PubMed ID: 6772941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
    J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow involvement in Hodgkin's disease: pathology and response to MOPP chemotherapy.
    Myers CE; Chabner BA; De Vita VT; Gralnick HR
    Blood; 1974 Aug; 44(2):197-204. PubMed ID: 4850810
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte ATP-ase activity in treated cases of Hodgkin's disease.
    Ellegaard J; Traunberg H; Esmann V
    Scand J Haematol; 1975 Sep; 15(2):88-95. PubMed ID: 127378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical demonstration of cathepsin B in the macrophages of benign and malignant lymphoid tissues.
    Crocker J; Burnett D; Jones EL
    J Pathol; 1984 Jan; 142(1):87-94. PubMed ID: 6366177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood Hodgkin's disease in Uganda: a ten year experience.
    Olweny CL; Katongole-Mbidde E; Kiire C; Lwanga SK; Magrath I; Ziegler JL
    Cancer; 1978 Aug; 42(2):787-92. PubMed ID: 687386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
    Hovgaard DJ; Nissen NI
    J Clin Oncol; 1992 Mar; 10(3):390-7. PubMed ID: 1740678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hodgkin's disease in the bone marrow.
    Weiss RB; Brunning RD; Kennedy BJ
    Cancer; 1975 Dec; 36(6):2077-83. PubMed ID: 1203865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    Aisenberg AC
    Am J Med; 1983 Sep; 75(3):449-54. PubMed ID: 6688502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].
    Tigges FJ; Hiller E; Schmülling RM; Waller HD; Wilms K
    Blut; 1978 Aug; 37(2):83-8. PubMed ID: 678681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytological basis of histological typing of diffuse Hodgkin's disease. Demonstration of an implied misnomer in the terminology of the Rye classification.
    Livesey AE; Sutherland FI; Brown RA; Beck JS; Macgillivray JB; Slidders W
    J Clin Pathol; 1978 Jun; 31(6):551-9. PubMed ID: 670411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chemotherapy (MOPP) following radiotherapy in stage I to III Hodgkin's disease: analysis of 110 cases.
    Tura S; Lauria F; Baccarani M; Fiacchini M; Frezza R; Mazza P; Babini L; Sciascia R; Emiliani E; Barbieri E
    Haematologica; 1979 Feb; 64(1):50-60. PubMed ID: 109365
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy.
    Klener P; Donner L; Roth Z
    Neoplasma; 1976; 23(3):315-22. PubMed ID: 958533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hodgkin's disease in South African children.
    Jacobson RJ; Klappenbach RS; Clinton C; de Moor NG; Wong O
    S Afr Med J; 1981 Jan; 59(5):133-7. PubMed ID: 7455844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.